This inventor holds 8 USPTO granted patents. Top assignees: Eli Lilly and Company, Other. Active years: 1976-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1976-1982
Title: **The Innovations of Edward L. Smithwick, Jr.**
Introduction
Edward L. Smithwick, Jr. is an accomplished inventor based in Indianapolis, IN, known for his significant contributions to the field of pharmaceuticals. With a total of eight patents to his name, his work primarily revolves around analgesic compounds, showcasing his commitment to advancing medical science and improving patient care.
Latest Patents
Among his latest patents, Edward has developed novel analgesic compounds, including formulations that incorporate specific chiral characteristics. These innovative compounds and their pharmaceutically acceptable non-toxic acid addition salts represent a meaningful advancement in pain management therapies, highlighting his focus on both efficacy and safety in pharmaceutical development.
Career Highlights
Edward's career is marked by his tenure at Eli Lilly and Company, a leading global pharmaceutical company where he contributed to various projects enhancing medicinal formulations. His expertise and dedication in the field have yielded important solutions within the pharmaceutical landscape, and his patents serve as a testament to his innovative approach to drug development.
Collaborations
Throughout his career, Edward has had the opportunity to collaborate with esteemed colleagues, including Robert C. Frederickson and Robert T. Shuman. These partnerships have facilitated knowledge exchange and fostered a collaborative environment that has likely influenced the successful outcomes of their collective research.
Conclusion
Edward L. Smithwick, Jr. continues to make notable strides in the pharmaceutical industry through his innovative contributions and patented inventions. His dedication to developing effective analgesic compounds not only underscores his expertise but also reflects his commitment to enhancing healthcare practices. As he progresses in his career, the impact of his work is sure to resonate within the field for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile